Skip to main content

Suicidality

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
CAMSN/A1 trial
Active Trials
NCT01334372Completed48
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
accelerated Thetaburst stimulationN/A1 trial
Active Trials
NCT04197765Active Not Recruiting40Est. Jan 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Angeles Therapeuticsaccelerated Thetaburst stimulation
Colorado TherapeuticsCAMS

Clinical Trials (2)

Total enrollment: 88 patients across 2 trials

NCT04197765Angeles Therapeuticsaccelerated Thetaburst stimulation

acTBS Treatment for Inpatient Subjects With Suicidality

Start: Jan 2020Est. completion: Jan 202940 patients
N/AActive Not Recruiting

Intensive Outpatient Treatment for Suicidal Veterans

Start: Feb 200748 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.